SC 13G

Company

AIM ImmunoTech Inc.

Filed

September 7, 2016

Accession Number

0001193125-16-702364

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →